Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Current Pulmonology Reports
Erschienen in:

25.05.2024 | REVIEW

Hypersensitivity Pneumonitis: A Silent Epidemic?

verfasst von: Kavitha Selvan, Cathryn T. Lee

Erschienen in: Current Pulmonology Reports | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Hypersensitivity pneumonitis (HP), along with interstitial lung disease as a whole, is a disorder with rising incidence, morbidity, and potentially mortality. Herein we review latest updates on epidemiology, environmental exposures, diagnosis, and treatment of this devastating disorder.

Recent Findings

Both the American Thoracic Society as well as the American College of Chest Physicians have recently released diagnostic guidelines for HP, offering an opportunity to standardize patient care and research in the coming years. Novel exposures associated with HP highlight its ever-changing epidemiology amidst a world threatened by climate change.

Summary

As diagnosis and treatment become more standardized for hypersensitivity pneumonitis, the varied presentations, exposures, and outcomes of the disorder lend itself to future research regarding both novel threats as well as precision approaches to care for patients with this heterogenous and incompletely understood disease.
Literatur
1.
2.
Fernández Pérez ER, Kong AM, Raimundo K, Koelsch TL, Kulkarni R, Cole AL. Epidemiology of hypersensitivity pneumonitis among an insured population in the United States: a claims-based cohort analysis. Annals ATS. 2018;15:460–9.CrossRef
3.
Copeland CR, Donnelly EF, Mehrad M, Ding G, Markin CR, Douglas K, et al. The association between exposures and disease characteristics in familial pulmonary fibrosis. Ann Am Thorac Soc. 2022;19:2003–12.PubMedPubMedCentralCrossRef
4.
Cano-Jiménez E, Villar Gómez A, Velez Segovia E, Aburto Barrenechea M, Sellarés Torres J, Francesqui J, et al. Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study. ERJ Open Res. 2024;10:00405–2023.PubMedPubMedCentralCrossRef
5.
Yamashita S, Okamoto T, Kawahara T, Tateishi T, Anzai T, Takahashi K, et al. Database analysis of hypersensitivity pneumonitis in Japan. Respir Investig. 2023;61:172–80.PubMedCrossRef
6.
Jung HI, Nam DR, You S-H, Jung J-W, Gu K-M, Jung S-Y. Nationwide study of the epidemiology, diagnosis, and treatment of hypersensitivity pneumonitis in Korea. J Korean Med Sci. 2024;39:e96.PubMedPubMedCentralCrossRef
7.
Thomeer M, Demedts M, Vandeurzen K, VRGT Working Group on Interstitial Lung Diseases. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg. 2001;56:163–72.PubMedCrossRef
8.
Duchemann B, Annesi-Maesano I, Jacobe de Naurois C, Sanyal S, Brillet P-Y, Brauner M, et al. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur Respir J. 2017;50:1602419.PubMedCrossRef
9.
Dhooria S, Sehgal IS, Agarwal R, Muthu V, Prasad KT, Kathirvel S, et al. Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 3089 subjects. PLoS ONE. 2022;17:e0271665.PubMedPubMedCentralCrossRef
10.
Singh S, Bairwa M, Collins B, Sharma B, Joshi J, Talwar D, et al. Survival predictors of interstitial lung disease in India: Follow-up of Interstitial Lung Disease India registry. Lung India. 2021;38:5–11.PubMedCrossRef
11.
• Kaul B, Cottin V, Collard HR, Valenzuela C. Variability in global prevalence of interstitial lung disease. Front Med (Lausanne). 2021;8:751181. Comprehensive review of the comparative epidemiology of HP across the globe.PubMedCrossRef
12.
Vasakova M, Selman M, Morell F, Sterclova M, Molina-Molina M, Raghu G. Hypersensitivity pneumonitis: Current concepts of pathogenesis and potential targets for treatment. Am J Respir Crit Care Med. 2019;200:301–8.PubMedCrossRef
13.
Selman M, Pardo A, King TE. Hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2012;186:314–24.PubMedCrossRef
14.
Joshi AD, Fong DJ, Oak SR, Trujillo G, Flaherty KR, Martinez FJ, et al. Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2009;179:705–16.PubMedCrossRef
15.
Agostini C, Calabrese F, Poletti V, Marcer G, Facco M, Miorin M, et al. CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis. Respir Res. 2005;6:20.PubMedPubMedCentralCrossRef
16.
Buendia-Roldan I, Fernandez R, Mejia M, Juarez F, Ramirez-Martinez G, Montes E, et al. Risk factors associated with the development of interstitial lung abnormalities. Eur Respir J. 2021;58:2003005.PubMedCrossRef
17.
Adegunsoye A, Oldham JM, Demchuk C, Montner S, Vij R, Strek ME. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med. 2016;114:53–60.PubMedPubMedCentralCrossRef
18.
Kalra SS, Jaber JF, Alzghoul B, Jansen B, Innabi A, Tran AB, et al. Hypersensitivity pneumonitis with and without autoimmune features: a clinical comparative analysis. Lung. 2022;200:763–71.PubMedCrossRef
19.
•• Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, et al. Diagnosis of hypersensitivity pneumonitis in adults: an official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2020;202:e36–69. Clinical practice guidelines published in 2020 by the ATS/JRS/ALAT on the diagnosis of HP.PubMedPubMedCentralCrossRef
20.
•• Pérez ERF, Travis WD, Lynch DA, Brown KK, Johannson KA, Selman M, et al. Diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report. Chest. 2021;160:e97-156. Expert guidelines published in 2021 by the CHEST Foundation on the diagnosis and management of HP.CrossRef
21.
Vasakova M, Morell F, Walsh S, Leslie K, Raghu G. Hypersensitivity pneumonitis: Perspectives in diagnosis and management. Am J Respir Crit Care Med. 2017;196:680–9.PubMedCrossRef
22.
Salisbury ML, Myers JL, Belloli EA, Kazerooni EA, Martinez FJ, Flaherty KR. Diagnosis and treatment of fibrotic hypersensitivity pneumonia. Where we stand and where we need to go. Am J Respir Crit Care Med. 2017;196:690–9.PubMedPubMedCentralCrossRef
23.
Blanc PD, Annesi-Maesano I, Balmes JR, Cummings KJ, Fishwick D, Miedinger D, et al. The occupational burden of nonmalignant respiratory diseases. An official american thoracic society and european respiratory society statement. Am J Respir Crit Care Med. 2019;199:1312–34.PubMedPubMedCentralCrossRef
24.
Lee CT, Adegunsoye A, Chung JH, Ventura IB, Jablonski R, Montner S, et al. Characteristics and prevalence of domestic and occupational inhalational exposures across interstitial lung diseases. Chest. 2021;160:209–18.PubMedPubMedCentralCrossRef
25.
Lee CT, Strek ME, Adegunsoye A, Wong AW, Assayag D, Cox G, et al. Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis. Respirology. 2022;27:635–44.PubMedPubMedCentralCrossRef
26.
Petnak T, Moua T. Exposure assessment in hypersensitivity pneumonitis: a comprehensive review and proposed screening questionnaire. ERJ Open Res. 2020;6(3):00230–2020.PubMedPubMedCentralCrossRef
27.
Walters GI, Mokhlis JM, Moore VC, Robertson AS, Burge GA, Bhomra PS, et al. Characteristics of hypersensitivity pneumonitis diagnosed by interstitial and occupational lung disease multi-disciplinary team consensus. Respir Med. 2019;155:19–25.PubMedCrossRef
28.
Moran-Mendoza O, Aldhaheri S, Black CJA, Clements-Baker M, Khalil M, Boag A. Mold in foam pillows and mattresses: a novel cause of hypersensitivity pneumonitis. Chest. 2021;160:e259–63.PubMedCrossRef
29.
30.
Walters GI, Trotter S, Sinha B, Richmond Z, Burge PS. Biopsy-proven hypersensitivity pneumonitis caused by a fluorocarbon waterproofing spray. Occup Med (Lond). 2017;67:308–10.PubMedCrossRef
31.
Walters GI, Huntley CC. Novel occupational causes of hypersensitivity pneumonitis. Curr Opin Allergy Clin Immunol. 2023;23:85–91.PubMedCrossRef
32.
Kutsuzawa N, Takihara T, Shiraishi Y, Kajiwara H, Imanishi T, Fukutomi Y, et al. Occupational hypersensitivity pneumonitis in a Japanese citrus farmer. Intern Med. 2021;60:3581–4.PubMedPubMedCentralCrossRef
33.
Ishiguro T, Kawai S, Kojima A, Shimizu Y, Kamei K, Takayanagi N. Occupational hypersensitivity pneumonitis in a koji brewer. Clin Case Rep. 2018;6:461–4.PubMedPubMedCentralCrossRef
34.
Armentia A, Fernández S, San Miguel Rodríguez A, San Miguel Hernández A, Corell A, Gayoso M. Occupational hypersensitivity pneumonitis caused by fossil-containing rocks. Clinica Chimica Acta. 2022;524:139–45.CrossRef
35.
Barnes H, Morisset J, Molyneaux P, Westall G, Glaspole I, Collard HR, et al. A systematically derived exposure assessment instrument for chronic hypersensitivity pneumonitis. Chest. 2020;157:1506–12.PubMedPubMedCentralCrossRef
36.
Barnes H, Troy L, Lee CT, Sperling A, Strek M, Glaspole I. Hypersensitivity pneumonitis: Current concepts in pathogenesis, diagnosis, and treatment. Allergy. 2022;77(2):442–53.PubMedCrossRef
37.
Jenkins AR, Chua A, Chami H, Diaz-Mendoza J, Duggal A, Knight S, et al. Questionnaires or serum immunoglobulin G testing in the diagnosis of hypersensitivity pneumonitis among patients with interstitial lung disease. Ann Am Thorac Soc. 2021;18:130–47.PubMedCrossRef
38.
Johannson KA, Barnes H, Bellanger A-P, Dalphin J-C, Fernández Pérez ER, Flaherty KR, et al. Exposure assessment tools for hypersensitivity pneumonitis. An official american thoracic society workshop report. Annals ATS. 2020;17:1501–9.CrossRef
39.
Demirkol B, Satici C, Tanriverdi E, Eren R, Altundas Hatman E, Yardimci HA, et al. Serum specific antibodies do not seem to have an additional role in the diagnosis of hypersensitivity pneumonitis. Med Lav. 2023;114:e2023042.PubMedPubMedCentral
40.
Chelala L, Adegunsoye A, Cody BA, Husain AN, Chung JH. Updated imaging classification of hypersensitivity pneumonitis. Radiol Clin North Am. 2022;60:901–13.PubMedCrossRef
41.
Brixey AG, Oh AS, Alsamarraie A, Chung JH. Pictorial review of fibrotic interstitial lung disease on high-resolution CT scan and updated classification. Chest. 2024;S0012–3692(23):05829–34.
42.
Marinescu D-C, Hague CJ, Muller NL, Murphy D, Churg A, Wright JL, et al. Integration and application of radiologic patterns from clinical practice guidelines on idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis. Chest. 2023;164:1466–75.PubMedCrossRef
43.
44.
Churg A, Bilawich A, Wright JL. Pathology of chronic hypersensitivity pneumonitis what is it? what are the diagnostic criteria? why do we care? Arch Pathol Lab Med. 2018;142:109–19.PubMedCrossRef
45.
Castonguay MC, Ryu JH, Yi ES, Tazelaar HD. Granulomas and giant cells in hypersensitivity pneumonitis. Hum Pathol. 2015;46:607–13.PubMedCrossRef
46.
Chiba S, Tsuchiya K, Akashi T, Ishizuka M, Okamoto T, Furusawa H, et al. Chronic hypersensitivity pneumonitis with a usual interstitial pneumonia-like pattern: Correlation between histopathologic and clinical findings. Chest. 2016;149:1473–81.PubMedCrossRef
47.
Botelho AB, Ferreira RG, Coletta ENAM, Cerezoli MT, Martins RB, Gomes PS, et al. Transbronchial biopsy in chronic hypersensitivity pneumonitis. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38:e2021018.PubMedPubMedCentral
48.
Troy LK, Grainge C, Corte TJ, Williamson JP, Vallely MP, Cooper WA, et al. Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. Lancet Respir Med. 2020;8:171–81.PubMedCrossRef
49.
Hetzel J, Wells AU, Costabel U, Colby TV, Walsh SLF, Verschakelen J, et al. Transbronchial cryobiopsy increases diagnostic confidence in interstitial lung disease: a prospective multicentre trial. Eur Respir J. 2020;56:1901520.PubMedCrossRef
50.
51.
Fernández Pérez ER, Swigris JJ, Forssén AV, Tourin O, Solomon JJ, Huie TJ, et al. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest. 2013;144:1644–51.PubMedPubMedCentralCrossRef
52.
Aronson KI, O’Beirne R, Martinez FJ, Safford MM. Barriers to antigen detection and avoidance in chronic hypersensitivity pneumonitis in the United States. Respir Res. 2021;22:225.PubMedPubMedCentralCrossRef
53.
Pitre T, Kawano-Dourado L, Kachkovski GV, Leung D, Leung G, Desai K, et al. Systemic corticosteroids in fibrotic lung disease: a systematic review and meta-analysis. BMJ Open Respir Res. 2023;10:e002008.PubMedPubMedCentralCrossRef
54.
De Sadeleer LJ, Hermans F, De Dycker E, Yserbyt J, Verschakelen JA, Verbeken EK, et al. Effects of corticosteroid treatment and antigen avoidance in a large hypersensitivity pneumonitis cohort: a single-centre cohort study. J Clin Med. 2018;8:14.PubMedPubMedCentralCrossRef
55.
De Sadeleer LJ, Hermans F, De Dycker E, Yserbyt J, Verschakelen JA, Verbeken EK, et al. Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study. Eur Respir J. 2020;55:1901983.PubMedCrossRef
56.
Mullin ML, Fernandez G, Marinescu D-C, Zheng B, Wong AW, Assayag D, et al. Impact of antigen exposure on outcomes and treatment response in fibrotic hypersensitivity pneumonitis. Chest. 2023;S0012–3692(23):05933.
57.
Zhang D, Adegunsoye A, Oldham JM, Kozlitina J, Garcia N, Poonawalla M, et al. Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. Eur Respir J. 2023;62:2300441.PubMedPubMedCentralCrossRef
58.
Morisset J, Johannson KA, Vittinghoff E, Aravena C, Elicker BM, Jones KD, et al. Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis. Chest. 2017;151:619–25.PubMedCrossRef
59.
Fiddler CA, Simler N, Thillai M, Parfrey H. Use of mycophenolate mofetil and azathioprine for the treatment of chronic hypersensitivity pneumonitis-A single-centre experience. Clin Respir J. 2019;13:791–4.PubMedCrossRef
60.
Adegunsoye A, Oldham JM, Fernández Pérez ER, Hamblin M, Patel N, Tener M, et al. Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis. ERJ Open Res. 2017;3:00016–2017.PubMedPubMedCentralCrossRef
61.
Ferreira M, Borie R, Crestani B, Rigaud P, Wemeau L, Israel-Biet D, et al. Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis (cHP): A retrospective, multicentric, observational study. Respir Med. 2020;172: 106146.PubMedCrossRef
62.
Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med. 2019;381:1718–27.PubMedCrossRef
63.
Fernández Pérez ER, Crooks JL, Lynch DA, Humphries SM, Koelsch TL, Swigris JJ, et al. Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety. Thorax. 2023;78:1097–104.PubMedCrossRef
64.
Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205:e18–47.PubMedPubMedCentralCrossRef
65.
Johannson KA, Kolb M, Fisher JH, Walsh SLF. Progressive pulmonary fibrosis: Putting the cart before the horse. Am J Respir Crit Care Med. 2022;206:1294–5.PubMedPubMedCentralCrossRef
66.
Pugashetti JV, Adegunsoye A, Wu Z, Lee CT, Srikrishnan A, Ghodrati S, et al. Validation of proposed criteria for progressive pulmonary fibrosis. Am J Respir Crit Care Med. 2023;207:69–76.PubMedCrossRef
67.
68.
Hambly N, Farooqi MM, Dvorkin-Gheva A, Donohoe K, Garlick K, Scallan C, et al. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry. Eur Respir J. 2022;60:2102571.PubMedCrossRef
69.
70.
Prior TS, Wälscher J, Gross B, Bendstrup E, Kreuter M. Clusters of comorbidities in fibrotic hypersensitivity pneumonitis. Respir Res. 2022;23:368.PubMedPubMedCentralCrossRef
71.
Petnak T, Cheungpasitporn W, Thongprayoon C, Sodsri T, Tangpanithandee S, Moua T. Phenotypic subtypes of fibrotic hypersensitivity pneumonitis identified by machine learning consensus clustering analysis. Respir Res. 2024;25:41.PubMedPubMedCentralCrossRef
72.
Fernández Pérez ER, Leach SM, Vestal B. Rationale and design of the prognostic transcriptomic signature in fibrotic hypersensitivity pneumonitis (PREDICT) study. ERJ Open Res. 2024;10:00625–2023.PubMedPubMedCentralCrossRef
73.
Kespohl S, Riebesehl J, Grüner J, Raulf M. Impact of climate change on wood and woodworkers-Cryptostroma corticale (sooty bark disease): A risk factor for trees and exposed employees. Front Public Health. 2022;10: 973686.PubMedPubMedCentralCrossRef
74.
Fernández Pérez ER, Sprunger DB, Ratanawatkul P, Maier LA, Huie TJ, Swigris JJ, et al. Increasing hypersensitivity pneumonitis–related mortality in the United States from 1988 to 2016. Am J Respir Crit Care Med. 2019;199:1284–7.PubMedCrossRef
Metadaten
Titel
Hypersensitivity Pneumonitis: A Silent Epidemic?
verfasst von
Kavitha Selvan
Cathryn T. Lee
Publikationsdatum
25.05.2024
Verlag
Springer US
Erschienen in
Current Pulmonology Reports / Ausgabe 3/2024
Elektronische ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-024-00354-z

Weitere Artikel der Ausgabe 3/2024

Autoimmune Pulmonary Alveolar Proteinosis: A Review of Pathogenesis and Emerging Therapies

  • REVIEW

Cystic Lung Diseases: A Radiology Primer

  • REVIEW

Assessment of Fluid Responsiveness with Critical Care Echocardiography: An Update

  • REVIEW

Cardiac Point-of-Care Ultrasound in Critical Care: Evolution, Current State, and Future Prospects

  • REVIEW

Reviews Evidence-Based Approach to Treatment and Prevention of Bronchiectasis

  • Review

Standardization of Point-of-Care-Ultrasonography in Critical Care: Enhancing Quality and Efficiency

  • REVIEW

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Therapiestopp bei älteren MS-Kranken kann sich lohnen

Eine Analyse aus Kanada bestätigt: Setzen ältere MS-Kranke die Behandlung mit Basistherapeutika ab, müssen sie kaum mit neuen Schüben und MRT-Auffälligkeiten rechnen.

Dank Nasenspray seltener in die Notaufnahme

Durch die intranasale Applikation von Etripamil lassen sich paroxysmale supraventrikuläre Tachykardien (PSVT) oft in Eigenregie beenden. Das erspart den Betroffenen das Aufsuchen von Notfallambulanzen.

Vorhofflimmern: So häufig kommt es bei Katheterablation zu Embolien

Arterielle Embolien – insbesondere Hirnembolien - sind eine mögliche periprozedurale Komplikation bei Katheterablation von Vorhofflimmern. Wie hoch ist das Risiko? Eine Analyse von weltweit mehr als 300.000 Ablationsprozeduren gibt darüber Auskunft.

NSCLC: Hirnmetastasen durch elektrische Felder eindämmen

Zur Behandlung von Hirnmetasen bei nicht-kleinzelligem Lungenkrebs (NSCLC) stehen verschiedene Optionen zur Verfügung. TTFields – eine lokoregionäre, nicht-invasive physikalische Therapie – könnte sich hier einreihen.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise